PAVM Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $2.87
Market Cap (MRQ) $18M
P/E (TTM) -0.3
EPS (TTM) $-10.52
Revenue (TTM) $112.0K
ROE (TTM) -33.3%
52W Range $3–$28

PAVM Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

Stock splits 2
Ex-date Split Type
Jan. 2, 2026 1-for-30 Reverse
Dec. 7, 2023 1-for-15 Reverse

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$71.0K
2021-12-31 → 2025-12-31
EPS$-5.63
2022-12-31 → 2025-12-31
Free Cash Flow$-5M
2020-12-31 → 2025-12-31
Net margin-10794.6%
2021-12-31 → 2025-12-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend PAVM 5Y avg Peer Median Verdict
P/E (TTM) -0.35Y avg ≈-0.5 ≈-0.5 · ·
P/S (TTM) 160.75Y avg ≈1656.4 ≈1656.4 2.1 Overvalued
P/B (MRQ) 0.55Y avg ≈-4.4 ≈-4.4 3.5 Undervalued
Price / FCF (TTM) -2.35Y avg ≈-17.4 ≈-17.4 · ·
Price / Cash Flow (TTM) -2.35Y avg ≈-18.0 ≈-18.0 · ·
Price / Tangible Book 0.1 · · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise -88.5%
Next Report Nov 10, 2026
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 Aug 11, 2026 $-0.87 $-0.48 -81.5%
March 31, 2026 May 14, 2026 $-4.42 $-0.71 -519.0%
Dec. 31, 2025 $-5.52 $-5.51 -0.22%
Sept. 30, 2025 $-8.70 $-5.20 -67.2%
June 30, 2025 $-22.20 $-3.98 -458.1%
March 31, 2025 $10.20 $-3.98 356.4%
Dec. 31, 2024 $8.70 $-17.44 149.9%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 17
Metric Trend 20252024202320222021
Revenue $71.0K$3M$2M$377.0K$500.0K
Cost of Revenue $218.0K$5M$6M$4M$585.0K
Gross Profit ····$-85.0K
R&D Expense $4M$6M$14M$25M$20M
SG&A Expense $16M$25M$31M$41M$25M
Operating Expenses $22M$47M$71M$91M$55M
Operating Income $-22M$-44M$-69M$-91M$-54M
Interest Income $29.0K$254.0K$505.0K$169.0K·
Other Non-op $19M$73M$-10M$-12M$-2M
Pretax Income $-2M$28M$-79M$-103M$-56M
Income Tax $0$0···
Net Income $401.0K$40M$-64M$-89M$-50M
EPS (Basic) $-5.63$99.15$-9.16$-15.03$-0.65
EPS (Diluted) $-5.63$14.90$-9.16$-15.03·
Shares (Basic) 670,466322,4077,231,5465,938,40677,515,767
Shares (Diluted) 670,4662,173,3987,231,5465,938,406·
EBITDA $-22M$-43M$-66M$-88M$-54M
Balance Sheet 23
Metric Trend 20252024202320222021
Cash & Equivalents $2M$1M$20M$40M$77M
Receivables $15.0K$18.0K$61.0K$17.0K$200.0K
Inventory ··$278.0K$111.0K·
Prepaid Expense $1M$961.0K$5M$4M$5M
Current Assets $3M$2M$24M$44M$83M
PP&E (Net) $77.0K$151.0K$2M$2M$2M
PP&E (Gross) $1M$1M$4M$3M$2M
Accum. Depreciation $1M$1M$2M$808.0K$138.0K
Intangibles ··$1M$3M$2M
Other Non-current Assets $56.0K$208.0K$1M$1M$725.0K
Total Assets $39M$31M$33M$54M$87M
Accounts Payable $678.0K$657.0K$2M$3M$3M
Accrued Liabilities $2M$5M$7M$4M$4M
Current Liabilities $15M$35M$54M$41M$8M
Capital Leases $2M$2M$3M$2M·
Total Liabilities $17M$38M$57M$43M$8M
Common Stock $1.0K$1.0K$9.0K$6.0K$86.0K
Paid-in Capital $268M$249M$238M$216M$198M
Retained Earnings $-259M$-255M$-294M$-228M$-139M
Treasury Stock ···$408.0K·
Stockholders' Equity $34M$-2M$-54M$-10M$62M
Liabilities + Equity $39M$31M$33M$54M$87M
Shares Outstanding 927,934373,3008,578,5056,300,70386,367,845
Cash Flow 13
Metric Trend 20252024202320222021
D&A $105.0K$1M$3M$2M$226.0K
Stock-based Comp $2M$6M$11M$20M$15M
Amort. of Intangibles $0$559.0K$2M$2M$146.0K
Other Non-cash $-7M$-81M$-2M$-4M·
Operating Cash Flow $-5M$-34M$-52M$-71M$-41M
CapEx $31.0K$55.0K$242.0K$2M$1M
Investing Cash Flow $-31.0K$-16M$758.0K$-5M$-4M
Stock Issued ·$2M$2M$79.0K$55M
Net Stock Activity ·$2M$2M·$55M
Financing Cash Flow $6M$31M$31M$38M$104M
Net Change in Cash $353.0K$-18M$-20M$-38M$60M
Taxes Paid $0····
Free Cash Flow $-5M$-34M$-52M$-73M$-42M
Profitability 8
Metric Trend 20252024202320222021
Gross Margin ····-17.0%
Operating Margin -30712.7%-1482.9%-2751.8%-24118.6%-10878.6%
Net Margin 564.8%1326.4%-2567.0%-23602.9%-10069.4%
Pretax Margin -3477.5%947.6%-3170.5%-27384.1%-11225.2%
EBITDA Margin -30564.8%-1443.0%-2634.5%-23466.8%-10878.6%
ROA 1.1%124.8%-147.4%-126.3%-94.3%
ROE 2.2%-141.3%202.1%-342.3%-158.4%
ROIC -64.2%····
Liquidity & Solvency 2
Metric Trend 20252024202320222021
Current Ratio 0.20.10.51.1·
Quick Ratio 0.10.00.41.0·
Efficiency 3
Metric Trend 20252024202320222021
Asset Turnover 0.00.10.10.00.0
Inventory Turnover ··33.0··
Receivables Turnover 4.375.964.13.55.0
Per Share 5
Metric Trend 20252024202320222021
Book Value / Share $36.60$-0.22$-6.28$-0.10$0.71
Revenue / Share $0.11$0.05$0.35··
Cash Flow / Share $-7.76$-0.51$-7.20··
Cash / Share $1.66$0.11$2.29$0.42$0.89
EPS (TTM) $-5.63$14.90$-9.16$-15.03·
Growth Rates 3
Metric Trend 20252024202320222021
Revenue YoY -97.6%19.8%563.1%-24.6%·
Revenue CAGR 3Y -42.7%81.6%···
Net Income YoY -99.0%····
Valuation (TTM) 10
Metric Trend 20252024202320222021
Revenue TTM $71.0K$3M$2M$377.0K$500.0K
Net Income TTM $401.0K$40M$-64M$-89M$-50M
Market Cap $6M$7M$35M$680M$3.19B
P/E -1.20.0-0.4-0.5·
P/S 86.72.314.11805.06373.9
P/B 0.2-2.8-0.7-70.351.7
P / Tangible Book 0.2···53.4
P / Cash Flow -1.2-0.2-0.7-9.6-78.5
P / FCF -1.2-0.2-0.7-9.4-75.8
Earnings Yield -84.9%2372.6%-222.3%-208.8%·

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $71.0K $3M $2M $377.0K $500.0K
Gross Margin % · · · · -17.0%
Operating Margin % -30712.7% -1482.9% -2751.8% -24118.6% -10878.6%
Net Income $401.0K $40M $-64M $-89M $-50M
Diluted EPS $-5.63 $14.90 $-9.16 $-15.03 ·

Institutional owners (13F) 23 filers · $5.6M total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 23
Value held $5.6M
New positions 4
Exited positions 5
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
4 (-14 vs prior Q) 5 (-7 vs prior Q) 6 (+6 vs prior Q) 3 (0 vs prior Q) +417K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
Two Seas Capital LP $2,741,542 461,539 48.64% Shares
FIRST MANHATTAN CO. LLC. $1,977,491 332,911 35.08% Shares
VANGUARD CAPITAL MANAGEMENT LLC $365,928 61,604 6.49% Shares
GEODE CAPITAL MANAGEMENT, LLC $217,871 36,678 3.87% Shares
VANGUARD FIDUCIARY TRUST CO $152,094 25,605 2.70% Shares
BlackRock, Inc. $101,526 17,092 1.80% Shares
VANGUARD GROUP INC $75,620 342,171 1.34% Shares
CWM, LLC $1,594 157 0.03% Shares
MORGAN STANLEY $968 163 0.02% Shares
BARCLAYS PLC $446 75 0.01% Shares
SBI Securities Co., Ltd. $398 67 0.01% Shares
CIBC Private Wealth Group LLC $360 836 0.01% Shares
UBS Group AG $339 57 0.01% Shares
WELLS FARGO & COMPANY/MN $267 45 0.00% Shares
Allworth Financial LP $30 5 0.00% Shares
Binnacle Investments Inc $29 67 0.00% Shares
Federation des caisses Desjardins du Quebec $23 4 0.00% Shares
OSAIC HOLDINGS, INC. $21 4 0.00% Shares
Steward Partners Investment Advisory, LLC $12 2 0.00% Shares
Caitong International Asset Management Co., Ltd $6 1 0.00% Shares
BNP PARIBAS FINANCIAL MARKETS $6 1 0.00% Shares
JONES FINANCIAL COMPANIES LLLP $5 1 0.00% Shares
ROYAL BANK OF CANADA $0 1 0.00% Shares

Activists & 5%+ owners 4 positions

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Aklog Lishan April 9, 2026 5.10% Initial filing Passive investment SEC
Lishan Aklog, M.D., Pavilion Venture Partners LLC July 6, 2018 · Initial filing Passive investment SEC
Ira Scott Greenspan ×3 filings July 6, 2018 · Initial filing · SEC
Lishan Aklog, Pavilion Venture Partners LLC, HCFP/Capital Partners III LLC ×3 filings April 26, 2018 · Initial filing Passive investment SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 19 insiders · 7 officers · 10 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Aklog Lishan Chairman and CEO April 2, 2026 A 357,614 0 0 $0
Dennis M Mcgrath President and CFO April 2, 2026 A 186,695 0 0 $0
Richard F Fitzgerald CFO and Secretary June 1, 2016 A 200 0 0 $0
Shaun O'Neil Chief Operating Officer April 2, 2026 A 115,598 0 0 $0
Victoria Tou-Ho Lee Chief Medical Officer April 2, 2026 A 71,666 0 0 $0
Michael Adam Gordon General Counsel April 2, 2026 A 115,000 0 0 $0
Brian J. Deguzman Chief Medical Officer Feb. 18, 2022 A 0 0 0 $0
Timothy E Baxter Director April 2, 2026 A 21,097 0 0 $0
Debra White Director April 2, 2026 A 21,097 0 0 $0
Sundeep Agrawal Director April 2, 2026 A 19,337 0 0 $0
Michael J Glennon Director April 2, 2026 A 21,653 0 0 $0
Ronald M Sparks Director April 2, 2026 A 21,097 0 0 $0
Joan B Harvey Director Feb. 22, 2024 A 65,000 0 0 $0
James L Cox Director Feb. 22, 2024 A 65,000 0 0 $0
David S. Battleman Director April 1, 2021 A · 0 0 $0
Joshua R Lamstein Director Dec. 21, 2017 J 163,177 0 0 $0
Matthew Sirovich 10% owner Nov. 25, 2020 S 1,027,744 0 0 $0
Ira Scott Greenspan 10% owner June 8, 2018 S 421,691 0 0 $0
Iv David Weild · April 1, 2021 A · 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 2 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
IWC · iShares Trust 0.01% 16,655 SH Sept. 11, 2026 Daily
VXF · VANGUARD INDEX FUNDS 0.00% 61,604 SH Aug. 19, 2026 Daily

PAVM Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 8 analysts BUY
Median target $36.50 +1171.8%
2 25.0% Strong Buy
5 62.5% Buy
1 12.5% Hold
0 0.0% Sell
0 0.0% Strong Sell

12-Month Price Target

2 analysts · 2026-09-29

Mean target $36.50 +1171.8%

← Below all targets Current price $2.87
Low$16.00 Mean$36.50 High$57.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
PAVM $6M -1.2 -97.6% 564.8% 2.2% ·
BEAT · · · · · ·
ICU · · · · · ·
HSCS · · · · · ·
FEMY $34M -1.2 40.8% -812.3% -505.0% ·
MODD $25M -0.4 · · -260.0% ·

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed Aug 13, 2026